Followers | 3348 |
Posts | 86291 |
Boards Moderated | 5 |
Alias Born | 10/05/2005 |
Tuesday, June 25, 2024 6:45:14 PM
Recent VRNA News
- Verona Pharma to Present Six Analyses of the Phase 3 ENHANCE Studies in COPD at CHEST 2024 • GlobeNewswire Inc. • 09/30/2024 06:00:00 AM
- Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024 • GlobeNewswire Inc. • 09/05/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 11:12:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:51:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:44:28 PM
- Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/08/2024 06:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:28:45 AM
- Verona Pharma to Present at 44th Annual Canaccord Growth Conference • GlobeNewswire Inc. • 07/30/2024 06:00:00 AM
- Verona Pharma to Report Second Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 07/25/2024 06:00:00 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 07/12/2024 08:04:11 PM
- Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine) • GlobeNewswire Inc. • 06/26/2024 08:57:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 01:09:53 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/10/2024 12:53:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:22:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:18:24 AM
- Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/09/2024 11:15:00 AM
- Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS • GlobeNewswire Inc. • 05/09/2024 11:00:00 AM
- Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024 • GlobeNewswire Inc. • 05/02/2024 06:00:00 AM
- Verona Pharma to Report First Quarter 2024 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 04/25/2024 06:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/08/2024 09:18:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 02:40:38 AM
- Andrew Fisher Joins Verona Pharma as General Counsel • GlobeNewswire Inc. • 03/04/2024 07:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 02:00:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:08:57 AM
- Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 07:00:00 AM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM